| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 4 Jul 2024 | 1 Jul 2024 |
| Sudarshan Pharma Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/07/2024 inter alia to consider and approve To consider proposal for raising of funds by way of issue of one or more of instruments comprising of equity shares convertible securities of any other description or warrants or debt securities through Private Placement / Preferential Issue / Qualified Institutions Placement or such other methods or combinations thereof and to approve ancillary actions for the above mentioned fund raising subject to such statutory / regulatory approvals as may be necessary. | ||
| Board Meeting | 27 May 2024 | 20 May 2024 |
| Sudarshan Pharma Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2024 inter alia to consider and approve Sudarshan Pharma Industries Limited hereby intimates the Stock Exchange about the Board Meeting to be scheduled on 27th May 2024 to discuss and consider the agendas as per the attachment annexed. APPOINTMENT OF MR NILESH THAKKAR , DR VISHVAS JOSHI, DR TAPAS KUMAR NANDI AND MR NIRAV SHAH AT THE BOARD MEETING HELD ON 27.05.2024 (As Per BSE Announcement dated on 27.05.2024) | ||
| Board Meeting | 28 Mar 2024 | 22 Mar 2024 |
| Sudarshan Pharma Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/03/2024 inter alia to consider and approve 1. To give authority to appoint consultants and/or representatives. 2. To avail the credit facility. & to consider and discuss any other matter. Sudarshan Pharma Industries Limited hereby intimates the Stock Exchange about the outcome of the meeting of the Board held on 28th March,2024. (As Per BSE Announcement dated on 28.03.2024) | ||
| Board Meeting | 12 Dec 2023 | 12 Dec 2023 |
| Sudarshan Pharma Industries Limited hereby intimates the Stock Exchange about the Outcome of the Board Meeting held on December 12, 2023. Agendas discussed in the Board Meeting and the subsequent Outcome are attached in the PDF herewith. Sudarshan Pharma Industries Limited hereby intimates the Stock Exchange about the Outcome of the Board Meeting held on December 12, 2023. Details of the Agendas discussed and the outcome of the Meeting is attached in the PDF herewith. Sudarshan Pharma Industries Limited hereby intimates the Stock Exchange about the Outcome of the Board Meeting held on December 12, 2023. Details of the Agendas discussed along with the Outcome of the Meeting is attached in the PDF herewith. Inter-alia along with other items: 1. Appointment of Mr. Sachin Mehta as the Chief Financial Officer of the Company in addition to being the Joint Managing Director of the Company. 2. Resignation of Mr. Nilesh Thakkar (DIN: 10044097) as an Additional Director in the category of Non-Executive Director. With reference to the captioned subject matter and in compliance with Regulation 30 read with Para A of Part A of Schedule II of the SEBI (LODR) Regulations, 2015, of SEBI (Listing Obligation & Disclosure Requirements) (LODR) Regulations, 2015, This is to inform you that Mr. Nilesh Thakkar, has resigned from the position of Additional Director of the company with effect from 12th December, 2023 due to other commitments and certain other pre-occupations and as stated in the resignation letter as enclosed herewith pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements), 2015. The formal acceptance of the same was placed in the Board Meeting. 3. To approve related party transaction with the following Companies: (a) Ratna Lifesciences Private Limited. (b) Lifescience Chemical Private Limited (As Per BSE Bulletin Dated on 12/12/2023) | ||
| Board Meeting | 10 Nov 2023 | 3 Nov 2023 |
| Sudarshan Pharma Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2023 inter alia to consider and approve Sudarshan Pharma Industries Limited hereby intimates the Stock Exchange about the intimation of the Board Meeting to be held on 10th November 2023. Sudarshan Pharma Industries Limited hereby intimates the Stock Exchange about the Un-Audited Standalone and Consolidated financial results for the Half year ended September 30, 2023, along with the Limited Review Report of the Auditors thereon. And also puts forward the outcome of other agendas considered in the meeting held on November 10, 2023 as per attachment . (As Per BSE Announcement dated on 10.11.2023) | ||
| Board Meeting | 18 Aug 2023 | 12 Aug 2023 |
| Sudarshan Pharma Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/08/2023 inter alia to consider and approve To give approval for incorporating a subsidiary company in the name and style of LIFESCIENCES CHEMICAL PRIVATE LIMITED in the state of Gujarat subject to approval of registrar of companies as may be required from time to time. Sudarshan Pharma Industries Limited hereby intimates the Stock Exchange about the outcome of the meeting of the Board held on 18th August,2023 (As Per BSE Announcement dated on 18.08.2023) | ||
| Board Meeting | 2 Aug 2023 | 27 Jul 2023 |
| Sudarshan Pharma Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/08/2023 inter alia to consider and approve With reference to the captioned subject matter Notice is hereby given that a Meeting of the Board of Directors of the company is scheduled to be held on Wednesday August 02 2023 at 02:00 PM inter-alia to consider and approve the following business: 1. To acquire RATNA LIFESCIENCES PRIVATE LIMITED (herein after referred as a Company) as the Wholly-Owned Subsidiary. 2. To incorporate a Subsidiary Company. & to consider and discuss any other matter. The Board of Directors at its meeting held on 02nd August, 2023 approved the agenda contained in the Outcome. Due to the restrictions on the Characters limit, the outcome of the Board meeting is attached in the PDF Format for your records. (As per BSE Announcement Dated on 02/08/2023) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
